The tumor inhibition rate of the RT + G-CSF mouse group (70.7%) is about twofold, fourfold, and sevenfold higher than those of RT only (34.3%), RT + aLy6G (17.6%), and RT + DPI (10.6%) mouse groups, respectively. This evidence concerns the gene CSF3 and neoplasm.